Week of February 27, 2023 |
|
Time to Ring the Bell Again!
Only about 10 months to go! BellRinger 2023 is off to a good start, with 112 riders signed up as of February 24.
When I think about the 2022 BellRinger ride, I can’t help but remember how this started. I had witnessed some notably successful cancer fundraising bike rides around the country, and also knew that success required a great cause, first-rate organizational support and a community that would rise to the challenge.
|
|
New Issue of The Ruesch Report Now Available
The Ruesch Center for the Cure of Gastrointestinal Cancers recently released the winter 2023 issue of its e-newsletter, The Ruesch Report. This issue includes a summary of what Ruesch researchers presented at the January 2023 ASCO GI Cancers Symposium, a look at a new clinical trial to evaluate the usefulness of circulating tumor DNA to identify the earliest signs of microscopic cancer relapse in patients after curative-intent therapies, and a review of the proceedings of the 2022 Ruesch Symposium. View the full issue.
|
|
Kowalczyk Named Chair for Urology Department
Keith Kowalczyk, MD (M’05), has been named physician executive director, MedStar Washington Urology Service Line, and chief of service, Department of Urology, MedStar Georgetown University Hospital, and promoted to academic chair, Georgetown University School of Medicine. He had held these positions on an interim basis since August 2021. Read the full announcement.
|
|
Center for Healthy Aging Symposium Abstract Deadline Extended
Abstracts are now being accepted through Tuesday, March 7, for the Second Annual Georgetown Center for Healthy Aging Symposium, “Advancing Knowledge About Aging to Improve Health and Health Care,” which takes place July 12. The symposium, held in-person and online, will include posters, oral presentations and panel discussions on special topics such as new research collaborations, career development, community outreach and grant proposal development. Upload abstracts via this Google Form. Contact Bill Rebeck, PhD, or Pamela Saunders, PhD, with questions.
|
|
Shared Resources Spotlight |
|
This weekly series showcases Georgetown University’s Shared Resources, which provide Georgetown Lombardi researchers with access to state-of-the-art equipment and technical expertise to support their work. |
|
Mass Spectrometry & Analytical Pharmacology Shared Resource – Proteomics
The Proteomics component of the Mass Spectrometry & Analytical Pharmacology Shared Resource (MSAPSR-Proteomics) provides Georgetown Lombardi investigators with access to an integrated suite of comprehensive molecular profiling services for targeted and untargeted identification and quantification of proteins/peptides and their modifications (including phosphorylation, acetylation, and O-GlcNAcylation) using nanoHPLC-MS/MS-based proteomic/peptidomic approaches. MSAPSR-Proteomics also supports studies in protein-protein interaction and identification of protein isoforms, as well as translational biomedical applications (e.g., discovery of protein biomarkers in biofluids and exosomes for diagnosis and prevention).
New technology now available: Imaging mass cytometry (IMC) scanning using the Standard Biotools (Fluidigm) Hyperion instrument for multiplex and spatial imaging of protein markers at the subcellular level in cancer and immune cells in tissue sections.
|
|
“Financial Toxicity in Cancer Survivors - Contributing Factors and Health Implications”
Tuesday February 28
8:00 - 9:00 a.m.
Presented by MedStar Endocrine Surgery Visiting Professor Cord Sturgeon, professor of surgery, chief of endocrine surgery at Northwestern Memorial Hospital, vice-chair of surgery, Northwestern Medicine, director of surgery, Northwestern Memorial Hospital Surgical Services, and physician director, informatics, Northwestern Medicine. Join this presentation in True Auditorium at MedStar Washington Hospital Center or via Microsoft Teams (Meeting ID: 219 887 003 459, Passcode: jZhZjW or call: 1-443-961-2657, Conf. ID: 382 172 822#).
|
|
Disability Employee Resource Group Interest Session
Tuesday, February 28
11:00 a.m. - 12:00 p.m.
The Disability Cultural Initiative is gauging interest in a Disability Employee Resource Group (ERG) to provide employees with opportunities for networking and community-building. Faculty and staff are invited to this session which will be Zoom-captioned. Contact disabilityculture@georgetown.edu with any accessibility requests. Register for this Zoom session.
|
|
IO/Heme Working Group Meeting
Thursday, March 2
5:00 - 6:00 p.m.
Joyce Slingerland, MD, PhD, professor, Department of Oncology, co-leader, Cancer Host Interaction Program, Georgetown Lombardi, presents “Elevated Estrone in Obesity Mediates Inflammation and Immune Evasion by ER+ Breast Cancer.” Join this meeting via Zoom.
|
|
Friday, March 3
12:00 - 1:00 p.m.
Presented by Dario Vignali, PhD, Frank Dixon Chair in Cancer Immunology, University of Pittsburgh School of Medicine. Join this lecture via Zoom.
|
|
Funding and Award Opportunities |
|
NEW ROS1ders Request for Application for ROS1+ Cancer Research Grant
The ROS1+ Cancer Innovation Award funds high-risk, high-reward research projects focused on ROS1+ cancer. The one-year, $75,000 seed grant can be used for preclinical, translational or clinical research and is open to investigators who hold a doctorate degree and a faculty appointment at an academic or nonprofit research institution anywhere in the world. Submit letter of intent (LOI) by March 31. Invited applicants must submit full application by June 15. View the RFA. Apply online at ProposalCentral.
|
|
Cancer Screening Research Network Funding Opportunities
The National Cancer Institute Division of Cancer Prevention has released three funding opportunity announcements for applications to create the Cancer Screening Research Network (CSRN). The CSRN will conduct rigorous, multi-center cancer screening trials and studies to evaluate emerging technologies and strategies for the purpose of cancer screening. The CSRN will have three different components for an integrated network.
View the following links for more information about each funding opportunity:
-
RFA-CA-23-020: ACCrual, Enrollment, and Screening Sites (ACCESS) Hub (UG1 Clinical Trial Required)
-
RFA-CA-23-021: Statistics and Data Management Center (UG1 Clinical Trial Required)
-
RFA-CA-23-022: Coordinating and Communication Center (UG1 Clinical Trial Required)
Application deadline: 5:00 p.m. ET, February 28
|
|
Request for Applications: Aging & Cancer Research with The Israel Cancer Research Fund
The Samuel Waxman Cancer Research Foundation and The Israel Cancer Research Fund are accepting applications for collaborative proposals to focus on aging and cancer. Projects must involve collaboration between two research groups — one in the U.S. and one in Israel — with different, but complementary expertise. Proposals must justify the partnership through synergistic scientific aims. Two collaborative projects will be funded. Each of these projects will be awarded $200,000 per year for two years, or a total of $400,000, with each research group receiving $100,000 per year ($200,000 total). Successful projects may be eligible for a third year of funding at the level of $100,000 ($50,000 per research group). View full RFA guidelines. Submit letters of intent via email by 5:00 p.m. ET, March 1 to Wylie Tene at wtene@waxmancancer.org.
|
|
BRCA Research and Education (CureBRCA) Grants
BRCA Research & Cure Alliance (CureBRCA) is now accepting funding applications for BRCA-related initiatives that involve prevention, detection, screening, and/or treatment for men at risk for BRCA-related cancers. All grant applications must address one of the following: identification of at-risk carriers, cancer prevention, early detection and screening for cancer, or novel treatment approaches pertaining to BRCA-related cancers. BRCA research, educational initiatives, or outreach efforts that cater to men who are at risk for BRCA mutations are desired. Applications that include collaboration, either across institutions, or within a single institution will be prioritized. Applications submitted from junior faculty or from underrepresented groups are encouraged. Applicants can request up to $500,000. View RFA for more information about eligibility, funding, evaluation, key dates, and application portal. Application deadline: March 1.
|
|
Damon Runyon Fellowship Award
The Damon Runyon Fellowship Award supports the training of the brightest postdoctoral scientists as they embark upon their research careers. This funding enables them to be mentored by established investigators in leading research laboratories across the country. Applicants must have completed one or more of the following degrees or its equivalent: MD, PhD, MD/PhD, DDS, DVM, DO. Candidates must apply for the fellowship under the guidance of a Sponsor — a scientist (tenured, tenure-track or equivalent position) capable of providing mentorship to the Fellow. Awards are made to institutions for the support of the Fellow under direct supervision of the Sponsor. Candidates who have already accepted a postdoctoral research fellowship award are not eligible. View additional eligibility criteria. This four-year award provides $60,000, $62,000, $64,000, and $66,000 in stipend support for years one, two, three, and four, respectively. In addition, an annual $2,000 expense allowance is awarded to the laboratory in which the Fellow is working and can be used by the Fellow for their educational and scientific expenses. The Foundation also provides a Dependent Child Allowance of $1,000 per child per year. View application guidelines. Application deadline: 4:00 p.m. ET, March 15, submitted through ProposalCentral.
|
|
AAI Careers in Immunology Fellowship Program
The AAI Careers in Immunology Fellowship Program supports the career development of young scientists by providing eligible PIs with one year of salary support for a trainee in their labs. The fellowship does not pay fringe benefits or other indirect costs to the institution. PIs must be independent research scientists who are AAI regular members in good standing. At the time of application, the PI should have no more than $350,000 U.S. dollars in total annual direct costs (excluding PI salary) from all funding sources, including start-up funds. Trainees must be AAI members in good standing at the time of application and have a current Trainee Certification Form on record with AAI. AAI encourages applications from and for women and underrepresented minority scientists. Award consideration is based on the merit of the PI’s proposed project, potential of the trainee, the quality of the training environment, and financial need. View application instructions. Deadline: 11:59 p.m. ET, March 15.
|
|
Children’s Cancer Foundation 2023 Call for Proposals
The Children's Cancer Foundation, Inc. (CCF) invites individuals from Maryland, D.C. and Northern Virginia conducting research and/or programs relevant to pediatric cancer to submit proposals for grant award consideration. CCF will be awarding multiple one-year grants for research; one one-year grant for research by a young investigator (Giant Food NextGen Award); and several one-year grants for support of an existing or new program that serves the pediatric cancer community. Applications must be submitted via email or file transfer service to Rose Ann Verrilli: rverrilli@childrenscancerfoundation.org no later than May 7 at 11:59 p.m. ET. Review and download application materials and guidelines.
|
|
Meetings in italics should be attended by all fellows.
|
|
9:00 AM | Breast Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 528212194)
11:00 AM | GU/Melanoma Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 796253566)
12:15 PM | Onc Board Review | Podium A / Zoom
4:00 PM | GU Tumor Board (on 1st/3rd Mondays of the month) | Podium A / Zoom (dial 646-558-8656; Meeting ID: 869742463)
|
|
9:00 AM | Hematology Path Conference - Inpatient Heme fellows + Outpatient Heme + BMT fellow | Podium A / Microsoft Teams (CME code: 81202; phone: 202-796-7323)
12:15 PM | ONC ITE – No Conference | Podium A / Zoom
4:00 PM | Liver Tumor Board | WebEx (dial 844-302-0362; Meeting number (access code): 711 507 430, password: Mse4mGSA2N5)
5:00 PM | Breast Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 93777073374; CME code: 80044)
|
|
8:00 AM | Thoracic Tumor Board – Thoracic Fellow | Podium A / Zoom (dial 646-558-8656; Meeting ID: 941 1630 5835)
12:15 PM | ONC ITE – No Conference | Podium A / Zoom
|
|
9:00 AM | Cancer Research Data Meeting | Speaker: Luz Ruiz | W302 New Research Building or Zoom
9:30 AM | Head and Neck Tumor Board - Thoracic Fellow attendance encouraged as clinic allows | Microsoft Teams
12:15 PM | No Conference | Podium A / Zoom
12:30 PM | GI Research Meeting | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)
|
|
7:00 AM | CNS Tumor Board | Zoom (dial 646-558-8656; Meeting ID: 378 807 316)
12:00 PM | Oncology Grand Rounds Lecture Series: “LAG3: The Third Checkpoint Inhibitor” | Dario Vignali, PhD | Zoom
12:00 PM | No Lecture | Zoom
|
|
Connect with Georgetown Lombardi on Social Media |
|
If you would like to share news or updates from your department, please get in touch with Sarah Riehl. |
|
|
|
|
|
|
